欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/1839/003
药品名称
Elvanse
活性成分
lisdexamfetamine dimesylate 70.0 mg
剂型
Capsule, hard
上市许可持有人
Shire Pharmaceuticals Ireland Limited Ireland
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Norway (NO)
Spain (ES)
Austria (AT)
Ireland (IE)
United Kingdom (Northern Ireland) (XI)
Luxembourg (LU)
Netherlands (NL)
Belgium (BE)
Denmark (DK)
Germany (DE)
Estonia (EE)
Poland (PL)
Elvanse
Portugal (PT)
Finland (FI)
许可日期
2012/12/18
最近更新日期
2024/11/22
药物ATC编码
N06BA12 lisdexamfetamine
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
PubAR
|
con261790_pdf
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase